ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 137 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,869,000 | -12.4% | 38,555 | -22.7% | 0.41% | -11.9% |
| Q4 2019 | $2,134,000 | +24.6% | 49,891 | +4.9% | 0.47% | +3.5% |
| Q3 2019 | $1,712,000 | -20.7% | 47,562 | -28.5% | 0.45% | +39.4% |
| Q2 2016 | $2,160,000 | +89.5% | 66,537 | +41.9% | 0.32% | +58.5% |
| Q1 2014 | $1,140,000 | -7.5% | 46,875 | -5.0% | 0.20% | -7.2% |
| Q4 2013 | $1,233,000 | -43.4% | 49,335 | -37.8% | 0.22% | -49.2% |
| Q3 2013 | $2,179,000 | -21.1% | 79,340 | -47.8% | 0.44% | -27.4% |
| Q2 2013 | $2,760,000 | – | 152,055 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |